可穿戴式多模态传感器用于量化左旋多巴在帕金森病中的心血管自主作用。

Frontiers in network physiology Pub Date : 2025-04-24 eCollection Date: 2025-01-01 DOI:10.3389/fnetp.2025.1543838
John A Berkebile, Omer T Inan, Paul A Beach
{"title":"可穿戴式多模态传感器用于量化左旋多巴在帕金森病中的心血管自主作用。","authors":"John A Berkebile, Omer T Inan, Paul A Beach","doi":"10.3389/fnetp.2025.1543838","DOIUrl":null,"url":null,"abstract":"<p><p>Levodopa is the most common therapy to reduce motor symptoms of parkinsonism. However, levodopa has potential to exacerbate cardiovascular autonomic (CVA) dysfunction that may co-occur in patients. Heart rate variability (HRV) is the most common method for assessing CVA function, but broader monitoring of CVA function and levodopa effects is typically limited to clinical settings and symptom reporting, which fail to capture its holistic nature. In this study, we evaluated the feasibility of a multimodal wearable chest patch for monitoring changes in CVA function during clinical and 24-h ambulatory (at home) conditions in 14 patients: 11 with Parkinson's disease (PD) and 3 with multiple system atrophy (MSA). In-clinic data were analyzed to examine the effects of orally administered levodopa on CVA function using a pre (OFF) and 60-min (ON) post-exposure protocol. Wearable-derived physiological markers related to the electrical and mechanical activity of the heart alongside vascular function were extracted. Pre-ejection period (PEP) and ratio of PEP to left ventricular ejection time index (LVETi) increased significantly (p <math><mrow><mo><</mo></mrow> </math> 0.05) following levodopa, indicating a decrease in cardiac contractility. We further explored dose-response relationships and how CVA responses differed between participants with orthostatic hypotension (OH) from those without OH. Heart rate variability, specifically root-mean-square-of-successive-differences (RMSSD), following levodopa decreased significantly more in participants with OH (n = 7) compared to those without (no-OH, n = 7). The results suggest that the wearable patch's measures are sensitive to CVA dynamics and provide exploratory insights into levodopa's potential role in inducing a negative inotropic effect and exacerbating CVA dysfunction. This work encourages further evaluation of these wearable-derived physiomarkers for quantifying CVA and informing individualized care of individuals with parkinsonism.</p>","PeriodicalId":73092,"journal":{"name":"Frontiers in network physiology","volume":"5 ","pages":"1543838"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058781/pdf/","citationCount":"0","resultStr":"{\"title\":\"Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism.\",\"authors\":\"John A Berkebile, Omer T Inan, Paul A Beach\",\"doi\":\"10.3389/fnetp.2025.1543838\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Levodopa is the most common therapy to reduce motor symptoms of parkinsonism. However, levodopa has potential to exacerbate cardiovascular autonomic (CVA) dysfunction that may co-occur in patients. Heart rate variability (HRV) is the most common method for assessing CVA function, but broader monitoring of CVA function and levodopa effects is typically limited to clinical settings and symptom reporting, which fail to capture its holistic nature. In this study, we evaluated the feasibility of a multimodal wearable chest patch for monitoring changes in CVA function during clinical and 24-h ambulatory (at home) conditions in 14 patients: 11 with Parkinson's disease (PD) and 3 with multiple system atrophy (MSA). In-clinic data were analyzed to examine the effects of orally administered levodopa on CVA function using a pre (OFF) and 60-min (ON) post-exposure protocol. Wearable-derived physiological markers related to the electrical and mechanical activity of the heart alongside vascular function were extracted. Pre-ejection period (PEP) and ratio of PEP to left ventricular ejection time index (LVETi) increased significantly (p <math><mrow><mo><</mo></mrow> </math> 0.05) following levodopa, indicating a decrease in cardiac contractility. We further explored dose-response relationships and how CVA responses differed between participants with orthostatic hypotension (OH) from those without OH. Heart rate variability, specifically root-mean-square-of-successive-differences (RMSSD), following levodopa decreased significantly more in participants with OH (n = 7) compared to those without (no-OH, n = 7). The results suggest that the wearable patch's measures are sensitive to CVA dynamics and provide exploratory insights into levodopa's potential role in inducing a negative inotropic effect and exacerbating CVA dysfunction. This work encourages further evaluation of these wearable-derived physiomarkers for quantifying CVA and informing individualized care of individuals with parkinsonism.</p>\",\"PeriodicalId\":73092,\"journal\":{\"name\":\"Frontiers in network physiology\",\"volume\":\"5 \",\"pages\":\"1543838\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058781/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in network physiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fnetp.2025.1543838\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in network physiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fnetp.2025.1543838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

左旋多巴是减轻帕金森运动症状最常见的治疗方法。然而,左旋多巴有可能加剧心血管自主神经(CVA)功能障碍,这可能在患者中同时发生。心率变异性(HRV)是评估CVA功能最常用的方法,但对CVA功能和左旋多巴效应的更广泛监测通常仅限于临床环境和症状报告,无法捕捉其整体性质。在这项研究中,我们评估了多模态可穿戴胸贴用于监测14例患者临床和24小时动态(在家)状态下CVA功能变化的可行性:11例帕金森病(PD)患者和3例多系统萎缩(MSA)患者。分析临床数据,采用暴露前(OFF)和暴露后60分钟(on)方案,检查口服左旋多巴对CVA功能的影响。提取了与心脏电和机械活动以及血管功能相关的可穿戴生理学标志物。左旋多巴后左室射血时间(PEP)和左室射血时间指数(LVETi)比值显著升高(p 0.05),表明心脏收缩力下降。我们进一步探讨了剂量-反应关系,以及有直立性低血压(OH)和无OH的参与者之间CVA反应的差异。与没有服用左旋多巴的参与者(n = 7)相比,服用左旋多巴的参与者(n = 7)的心率变异性,特别是连续差异的均方根(RMSSD)显著降低。结果表明,可穿戴贴片的测量对CVA动态敏感,并为左旋多巴在诱导负性肌力效应和加剧CVA功能障碍中的潜在作用提供了探索性见解。这项工作鼓励进一步评估这些可穿戴设备衍生的生理标志物,以量化CVA,并为帕金森病患者的个性化护理提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism.

Levodopa is the most common therapy to reduce motor symptoms of parkinsonism. However, levodopa has potential to exacerbate cardiovascular autonomic (CVA) dysfunction that may co-occur in patients. Heart rate variability (HRV) is the most common method for assessing CVA function, but broader monitoring of CVA function and levodopa effects is typically limited to clinical settings and symptom reporting, which fail to capture its holistic nature. In this study, we evaluated the feasibility of a multimodal wearable chest patch for monitoring changes in CVA function during clinical and 24-h ambulatory (at home) conditions in 14 patients: 11 with Parkinson's disease (PD) and 3 with multiple system atrophy (MSA). In-clinic data were analyzed to examine the effects of orally administered levodopa on CVA function using a pre (OFF) and 60-min (ON) post-exposure protocol. Wearable-derived physiological markers related to the electrical and mechanical activity of the heart alongside vascular function were extracted. Pre-ejection period (PEP) and ratio of PEP to left ventricular ejection time index (LVETi) increased significantly (p < 0.05) following levodopa, indicating a decrease in cardiac contractility. We further explored dose-response relationships and how CVA responses differed between participants with orthostatic hypotension (OH) from those without OH. Heart rate variability, specifically root-mean-square-of-successive-differences (RMSSD), following levodopa decreased significantly more in participants with OH (n = 7) compared to those without (no-OH, n = 7). The results suggest that the wearable patch's measures are sensitive to CVA dynamics and provide exploratory insights into levodopa's potential role in inducing a negative inotropic effect and exacerbating CVA dysfunction. This work encourages further evaluation of these wearable-derived physiomarkers for quantifying CVA and informing individualized care of individuals with parkinsonism.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信